BlackRock’s Traws Pharma TRAW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.38K | Sell |
9,941
-15
| -0.2% | -$21 | ﹤0.01% | 5450 |
|
|
2026
Q1 | $18.2K | Hold |
9,956
| – | – | ﹤0.01% | 5320 |
|
|
2025
Q4 | $11.3K | Hold |
9,956
| – | – | ﹤0.01% | 5278 |
|
|
2025
Q3 | $18.4K | Hold |
9,956
| – | – | ﹤0.01% | 5154 |
|
|
2025
Q2 | $14.7K | Hold |
9,956
| – | – | ﹤0.01% | 5180 |
|
|
2025
Q1 | $22.9K | Hold |
9,956
| – | – | ﹤0.01% | 5073 |
|
|
2024
Q4 | $88.4K | Hold |
9,956
| – | – | ﹤0.01% | 4814 |
|
|
2024
Q3 | $58.5K | Buy |
9,956
+1
| +0% | +$9 | ﹤0.01% | 4782 |
|
|
2024
Q2 | $111K | Hold |
9,955
| – | – | ﹤0.01% | 4674 |
|
|
2024
Q1 | $251K | Hold |
9,955
| – | – | ﹤0.01% | 4538 |
|
|
2023
Q4 | $186K | Hold |
9,955
| – | – | ﹤0.01% | 4661 |
|
|
2023
Q3 | $177K | Hold |
9,955
| – | – | ﹤0.01% | 4716 |
|
|
2023
Q2 | $294K | Hold |
9,955
| – | – | ﹤0.01% | 4630 |
|
|
2023
Q1 | $182K | Hold |
9,955
| – | – | ﹤0.01% | 4802 |
|
|
2022
Q4 | $161K | Hold |
9,955
| – | – | ﹤0.01% | 4908 |
|
|
2022
Q3 | $219K | Hold |
9,955
| – | – | ﹤0.01% | 4955 |
|
|
2022
Q2 | $329K | Hold |
9,955
| – | – | ﹤0.01% | 4898 |
|
|
2022
Q1 | $458K | Hold |
9,955
| – | – | ﹤0.01% | 4896 |
|
|
2021
Q4 | $635K | Sell |
9,955
-89
| -0.9% | -$7.16K | ﹤0.01% | 4804 |
|
|
2021
Q3 | $961K | Sell |
10,044
-12
| -0.1% | -$1.55K | ﹤0.01% | 4568 |
|
|
2021
Q2 | $1.74M | Sell |
10,056
-1,872
| -16% | -$424K | ﹤0.01% | 4338 |
|
|
2021
Q1 | $4.47M | Buy |
11,928
+9,595
| +411% | +$3.62M | ﹤0.01% | 3992 |
|
|
2020
Q4 | $407K | Hold |
2,333
| – | – | ﹤0.01% | 4377 |
|
|
2020
Q3 | $245K | Hold |
2,333
| – | – | ﹤0.01% | 4374 |
|
|
2020
Q2 | $495K | Buy |
2,333
+43
| +2% | +$6.57K | ﹤0.01% | 4211 |
|
|
2020
Q1 | $260K | Hold |
2,290
| – | – | ﹤0.01% | 4184 |
|
|
2019
Q4 | $329K | Buy |
+2,290
| New | +$428K | ﹤0.01% | 4235 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 5102 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 5103 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 5071 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 5078 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 5095 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 5097 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 5035 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 4900 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 4933 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 4987 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 4974 |
|
|
2013
Q4 | – | Hold |
0
| – | -$4K | – | 3146 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 3042 |
|
Other funds holding TRAW
LCM
VCM
DIG
VFT
VF
BlackRock's TRAW Position: Q2 2026 in Review
BlackRock reduced its Traws Pharma (TRAW) stake by 0.15% in Q2 2026, selling an estimated $21 and leaving 9,941 shares worth $8.38K. The position accounts for ﹤0.01% of the portfolio, ranked #5450.
BlackRock first reported a position in TRAW in Q4 2019 and has held it in 27 quarters since. The position peaked at $4.47M in Q1 2021. 21 funds tracked by Wall St. Rank hold TRAW as of Q2 2026.
- BlackRock held 9,941 shares of Traws Pharma worth $8.38K as of Q2 2026.
- BlackRock sold 15 Traws Pharma shares in Q2 2026, an estimated $21.
- Traws Pharma made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #5450 holding.
- BlackRock first reported a position in Traws Pharma in Q4 2019 and has held it in 27 quarters since.
- BlackRock's Traws Pharma position peaked at $4.47M in Q1 2021.
- 21 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.